BC

Broadfin Capital Portfolio holdings

AUM $403M
1-Year Est. Return 74.97%
This Quarter Est. Return
1 Year Est. Return
+74.97%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$645M
AUM Growth
-$45.1M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
57
New
Increased
Reduced
Closed

Top Buys

1
+$15.1M
2
+$6.16M
3
+$5.74M
4
RGLS
Regulus Therapeutics
RGLS
+$5.37M
5
BAX icon
Baxter International
BAX
+$4.1M

Top Sells

1
+$28.5M
2
+$17.9M
3
+$15.5M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$12.6M
5
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$12.2M

Sector Composition

1 Healthcare 91.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$55.8M 8.26%
3,455,710
-962,649
2
$49.2M 7.27%
4,436,726
3
$42.7M 6.32%
1,716,958
-1,145,220
4
$39.3M 5.81%
3,097,964
-962,883
5
$37.5M 5.54%
3,568,122
-565,342
6
$36.8M 5.44%
1,058,138
-199,749
7
$31.8M 4.7%
5,184,942
8
$30.3M 4.48%
1,770,940
+87,688
9
$29.1M 4.31%
2,490,801
10
$27.8M 4.12%
3,456,596
11
$25.8M 3.82%
3,011,323
+1,764,400
12
$19.9M 2.95%
2,886,795
+14,867
13
$19.3M 2.85%
2,487,622
+211,263
14
$18.5M 2.73%
1,494,402
-1,446,845
15
$17.4M 2.57%
6,892,500
-457,500
16
$13.7M 2.03%
1,948,554
17
$13M 1.92%
4,410,866
-711,228
18
$10.4M 1.54%
3,205,900
-1,597,628
19
$10.2M 1.51%
406,207
+129,187
20
$9.56M 1.41%
142,542
-4,203
21
$8.95M 1.32%
1,020,832
-426,034
22
$8.72M 1.29%
74,208
-106,992
23
$7.67M 1.13%
204,400
+92,900
24
$6.64M 0.98%
41,020
+206
25
$6.16M 0.91%
+45,000
1
2 3